Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection

Autor: Delphin, Marion, Mohammed, Khadija Said, Downs, Louise O, Lumley, Sheila F, Waddilove, Elizabeth, Okanda, Dorcas, Aliyan, Nadia, Van Schalkwyk, Marije, Anderson, Motswedi, Ocama, Ponsiano, Maponga, Tongai, Torimiro, Judith, Iwuji, Collins, Ndung'u, Thumbi, Matthews, Philippa C ^*, Taljaard, Jantjie ^*

Publikováno v: In The Lancet Gastroenterology & Hepatology April 2024 9(4):383-392

Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.: Journal of Clinical Virology 174 (2024) 105711

Autor: Lumley, Sheila F., Delphin, Marion, Mokaya, Jolynne, Tan, Cedric C.S., Martyn, Emily, Anderson, Motswedi, Li, Ka Chun, Waddilove, Elizabeth, Sukali, Gloria, Downs, Louise O., Said, Khadija, Okanda, Dorcas, Campbell, Cori, Harriss, Eli, Shimakawa, Yusuke, Matthews, Philippa C.

Publikováno v: In Journal of Clinical Virology October 2024 174

(Fasta files) Low frequency of Plasmodium falciparum hrp2/3 deletions from symptomatic infections at a primary healthcare facility in Kilifi, Kenya

Autor: Okanda Dorcas, Ndwiga Leonard, Osoti Victor, Achieng Nicole, Wambua Juliana, Ngetsa Caroline, Lubell-Doughtie Peter, Shankar Anuraj, Bejon Philip, Ochola-Oyier I Lynette

In this study, the presence of Pfhrp2/3 deletions was examined in uncomplicated malaria patients in Kilifi County, from a region of moderate-high malaria transmission. 345 samples were collected from the Pingilikani dispensary in 2019/2020 during rou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::334467b20cc49a4f60bd9967b998b14b

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Low frequency of Plasmodium falciparum hrp2/3 deletions from symptomatic infections at a primary healthcare facility in Kilifi, Kenya.

Autor: Okanda D; Biosciences Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Ndwiga L; Biosciences Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Osoti V; Biosciences Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Achieng N; Biosciences Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Wambua J; Biosciences Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Ngetsa C; Biosciences Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Lubell-Doughtie P; ONA Systems Inc, Burlington, VT, United States., Shankar A; Nuffield Department of Medicine, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, United Kingdom., Bejon P; Biosciences Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Nuffield Department of Medicine, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, United Kingdom., Ochola-Oyier LI; Biosciences Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Publikováno v: Frontiers in epidemiology [Front Epidemiol] 2023 Feb 21; Vol. 3, pp. 1083114. Date of Electronic Publication: 2023 Feb 21 (Print Publication: 2023).